Humanwell Healthcare Group Co Ltd (600079) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.038x

Based on the latest financial reports, Humanwell Healthcare Group Co Ltd (600079) has a cash flow conversion efficiency ratio of 0.038x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥829.91 Million ≈ $121.44 Million USD) by net assets (CN¥21.92 Billion ≈ $3.21 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Humanwell Healthcare Group Co Ltd worth for the company's overall valuation and market capitalisation.

Humanwell Healthcare Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Humanwell Healthcare Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Humanwell Healthcare Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Humanwell Healthcare Group Co Ltd ranked by their cash flow conversion efficiency. Explore Humanwell Healthcare Group Co Ltd cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
IONOS GROUP N
XETRA:IOS
0.148x
Acerinox
MC:ACX
0.020x
Jinneng Holding Shanxi Coal Industry Co Ltd
SHG:601001
0.030x
AVIC Capital Co Ltd
SHG:600705
-0.321x
Ningxia Orient Tantalum Industry Co Ltd
SHE:000962
-0.065x
Poonawalla Fincorp Limited
NSE:POONAWALLA
0.085x
UMICORE S.A UNSP.ADR 1/4
F:NVJ
N/A
Cia de Distribucion Integral
MC:LOG
1.722x

Annual Cash Flow Conversion Efficiency for Humanwell Healthcare Group Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Humanwell Healthcare Group Co Ltd from 1998 to 2025. View current stock price of Humanwell Healthcare Group Co Ltd for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥22.01 Billion
≈ $3.22 Billion
CN¥2.52 Billion
≈ $368.57 Million
0.114x +9.43%
2024-12-31 CN¥20.69 Billion
≈ $3.03 Billion
CN¥2.16 Billion
≈ $316.70 Million
0.105x +6.85%
2023-12-31 CN¥20.10 Billion
≈ $2.94 Billion
CN¥1.97 Billion
≈ $287.87 Million
0.098x -28.06%
2022-12-31 CN¥17.94 Billion
≈ $2.63 Billion
CN¥2.44 Billion
≈ $357.21 Million
0.136x -2.27%
2021-12-31 CN¥15.65 Billion
≈ $2.29 Billion
CN¥2.18 Billion
≈ $318.83 Million
0.139x -9.08%
2020-12-31 CN¥12.99 Billion
≈ $1.90 Billion
CN¥1.99 Billion
≈ $290.98 Million
0.153x +6.92%
2019-12-31 CN¥14.23 Billion
≈ $2.08 Billion
CN¥2.04 Billion
≈ $298.20 Million
0.143x +243.92%
2018-12-31 CN¥14.48 Billion
≈ $2.12 Billion
CN¥602.99 Million
≈ $88.24 Million
0.042x +1737.75%
2017-12-31 CN¥16.85 Billion
≈ $2.47 Billion
CN¥38.17 Million
≈ $5.59 Million
0.002x -94.84%
2016-12-31 CN¥11.98 Billion
≈ $1.75 Billion
CN¥526.48 Million
≈ $77.04 Million
0.044x +29.63%
2015-12-31 CN¥9.18 Billion
≈ $1.34 Billion
CN¥311.22 Million
≈ $45.54 Million
0.034x -61.38%
2014-12-31 CN¥5.73 Billion
≈ $838.16 Million
CN¥502.70 Million
≈ $73.56 Million
0.088x -10.50%
2013-12-31 CN¥5.08 Billion
≈ $743.41 Million
CN¥498.22 Million
≈ $72.90 Million
0.098x +107.76%
2012-12-31 CN¥3.65 Billion
≈ $534.05 Million
CN¥172.27 Million
≈ $25.21 Million
0.047x +57.24%
2011-12-31 CN¥3.14 Billion
≈ $459.33 Million
CN¥94.23 Million
≈ $13.79 Million
0.030x -37.27%
2010-12-31 CN¥2.33 Billion
≈ $340.61 Million
CN¥111.39 Million
≈ $16.30 Million
0.048x -35.56%
2009-12-31 CN¥2.08 Billion
≈ $304.49 Million
CN¥154.51 Million
≈ $22.61 Million
0.074x +163.33%
2008-12-31 CN¥1.24 Billion
≈ $181.47 Million
CN¥34.97 Million
≈ $5.12 Million
0.028x -40.22%
2007-12-31 CN¥1.17 Billion
≈ $170.79 Million
CN¥55.05 Million
≈ $8.06 Million
0.047x -38.05%
2006-12-31 CN¥1.11 Billion
≈ $162.28 Million
CN¥84.44 Million
≈ $12.36 Million
0.076x -53.95%
2005-12-31 CN¥768.89 Million
≈ $112.51 Million
CN¥127.13 Million
≈ $18.60 Million
0.165x +69.79%
2004-12-31 CN¥724.52 Million
≈ $106.02 Million
CN¥70.55 Million
≈ $10.32 Million
0.097x +37.37%
2003-12-31 CN¥681.54 Million
≈ $99.73 Million
CN¥48.31 Million
≈ $7.07 Million
0.071x +169.37%
2002-12-31 CN¥682.71 Million
≈ $99.90 Million
CN¥-69.77 Million
≈ $-10.21 Million
-0.102x -340.11%
2001-12-31 CN¥396.54 Million
≈ $58.03 Million
CN¥16.88 Million
≈ $2.47 Million
0.043x -47.20%
2000-12-31 CN¥325.09 Million
≈ $47.57 Million
CN¥26.20 Million
≈ $3.83 Million
0.081x +192.00%
1999-12-31 CN¥290.76 Million
≈ $42.55 Million
CN¥-25.47 Million
≈ $-3.73 Million
-0.088x -747.02%
1998-12-31 CN¥201.81 Million
≈ $29.53 Million
CN¥2.73 Million
≈ $399.87K
0.014x --

About Humanwell Healthcare Group Co Ltd

SHG:600079 China Drug Manufacturers - Specialty & Generic
Market Cap
$4.47 Billion
CN¥30.57 Billion CNY
Market Cap Rank
#3861 Global
#559 in China
Share Price
CN¥18.73
Change (1 day)
-0.27%
52-Week Range
CN¥16.37 - CN¥21.54
All Time High
CN¥37.30
About

Humanwell Healthcare (Group) Co.,Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers sufentanil citrate injection, an analgesic drug for combined anesthesia; remifentanil hydrochloride injection for induction of general anesthesia and maintenance of analgesia during general anesthesia; hydromorphone hydrochloride injection for pa… Read more